Nemorubicin 是一种 Doxorubicin 衍生物，具有抗肿瘤活性。它需要完整的核苷酸切除修复系统才能发挥活性。它对多药耐药表型的多种肿瘤细胞系具有细胞毒性。

Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile. The drug is active on tumors resistant to alkylating agents, topoisomerase II inhibitors and platinum derivatives.

108852-90-0

C32H37NO13

643.642

PNU 152243;Methoxymorpholinyldoxorubicin;奈莫柔比星;PNU-152243A

DMSO:45 mg/mL (69.91 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years